Article

Novel TB Vaccine Fails to Protect Infants

A tuberculosis (TB) vaccine candidate was safe and immunogenic but not efficacious in infants, researchers reported.

In a randomized trial of 2,797 infants, the vaccine candidate was well-tolerated compared with a placebo injection and induced "modest" cell-mediated immune responses, according to Helen McShane, MD, of the University of Oxford, and colleagues.

Read the full story: http://bit.ly/WY81Eh

Source: Medpage Today

Related Videos
Jaime Almandoz, MD, MBA
Martin Edelman, MD
Benjamin Chen, MD, PhD
1 expert in this video
Frederick L Locke, MD, Moffitt
4 experts are featured in this series.
1 expert is featured in this series.
4 experts are featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo